SEI Investments
LYEL icon

SEI Investments’s Lyell Immunopharma LYEL Stock Holding History

SEI Investments’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,795
Closed -$30.1K – 2863
2025
Q1 		$30.1K Hold
2,795
– – ﹤0.01% 2718
2024
Q4 		$35.8K Hold
2,795
– – ﹤0.01% 2690
2024
Q3 		$77.1K Buy
+2,795
New +$82.1K ﹤0.01% 2594
2022
Q4 		– Sell
-735
Closed -$108K – 2617
2022
Q3 		$108K Sell
735
-25
-3% -$3.38K ﹤0.01% 2552
2022
Q2 		$99K Buy
+760
New +$77.7K ﹤0.01% 2570

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SEI Investments's LYEL Position: Q2 2025 in Review

SEI Investments sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 2,795 shares — an estimated $30.1K sold.

SEI Investments first reported a position in LYEL in Q2 2022 and held it in 5 quarters. The position peaked at $108K in Q3 2022. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • SEI Investments reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • SEI Investments sold 2,795 Lyell Immunopharma shares in Q2 2025, an estimated $30.1K.
  • SEI Investments first reported a position in Lyell Immunopharma in Q2 2022 and held it in 5 quarters.
  • SEI Investments's Lyell Immunopharma position peaked at $108K in Q3 2022.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on SEI Investments's 13F filing for Q2 2025, filed 14 Aug 2025.